Acarbose Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: INSULIN GLARGINE (HOE901);   Drug: Insulin Glulisine;   Drug: Biphasic insulin aspart 30;   Drug: Repaglinide;   Drug: Acarbose;   Drug: Metformin Sponsor:   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2017 Category: Research Source Type: clinical trials